Avalon GloboCare Corp (NASDAQ:ALBT) said it had successfully launched its KetoAir breathalyzer in the US at the Hack Your Health by KetoCon 2024 Conference.
Avalon CEO David Jin told shareholders that the booth at the event in Austin “attracted a diverse group of potential clients and partners, including doctors, disease management companies, health and keto coaches, consumers, keto product manufacturers, and service providers interested in establishing a marketplace on our app and device.”
“Additionally, there was significant interest from brick-and-mortar retailers, key opinion leaders, and influencers,” he said.
At the conference, Avalon introduced the Zero to Keto program for health and keto coaches and announced plans to begin retail sales later this month, following the first shipment's arrival at the US distribution center.
"We believe the KetoAir breathalyzer will fill a market gap with its non-invasive daily test, offering a competitive edge due to its improved precision and effectiveness," Jin added. Consumers will be able to purchase the KetoAir breathalyzer exclusively on the company's new website, KetoAir.com, later this month.
The KetoAir breathalyzer is a device featuring Hot App shareable technology with AI-enabled software, specifically designed for ketogenic health management.
Leveraging nano-sensor-based technology and AI algorithms, the device assesses the user's ketosis status and seamlessly records diet and exercise details into the KetoAir app, available on both the Apple App Store and Google Play Store.